Differential patterns of evolution in acute middle cerebral artery infarction with perfusion-diffusion mismatch: Atherosclerotic vs. cardioembolic occlusion

被引:15
作者
Kim, Hye-Jin [1 ]
Yun, Sung-Cheol [2 ]
Cho, Yung-Hee [1 ]
Cho, A-Hyun [1 ]
Kwon, Sun U. [1 ]
Kim, Jong S. [1 ]
Kang, Dong-Wha [1 ]
机构
[1] Univ Ulsan, Dept Neurol, Asan Med Ctr, Coll Med, Seoul 138736, South Korea
[2] Univ Ulsan, Dept Prevent Med, Asan Med Ctr, Coll Med, Seoul 138736, South Korea
关键词
cardioembolism; intracranial atherosclerosis; magnetic resonance imaging; middle cerebral artery infarction; perfusion-diffusion mismatch;
D O I
10.1016/j.jns.2008.06.039
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: An acute perfusion-diffusion mismatch is known to be the strongest predictor of infarct growth. However, the differential patterns of clinical and radiological evolution according to stroke mechanism are unknown. Methods: The study retrospectively reviewed consecutive patients who had 1) acute middle cerebral artery (MCA) territory infarction, 2) diffusion- and perfusion-weighted imaging (DWI and PWI) and MR angiography within 24 h of onset, and follow-up DWI 5 days later, 3) stenosis (>= 50%) or occlusion of MCA on baseline imaging, 4) a baseline PWI-DWI mismatch > 20%, and 5) either atherosclerotic MCA disease (MCAD) or cardioembolism (CE). National Institutes of Health Stroke Scale (NIHSS) scores and infarct volume at baseline and 5 days were obtained. Results: Of 90 patients, 52 had MCAD and 38 had CE. At baseline, CE group had more severe stroke (median NIHSS, 9 vs. 5; p=0.001) and larger infarct volume (median 8.32 cc vs. 3.0 cc; p=0.034) than MCAD group. During the 1-week period, CE group had larger infarct volume growth (median 12.85 cc vs. 3.02 cc; p=0.004) than MCAD group, although clinical improvement based on NIHSS (baseline minus 5-day) tended to be higher for CE than MCAD group (median 3 vs. 1; p=0.08). The correlation between infarct volume and NIHSS score was stronger in CE (r=0.841) compared to MCAD (r=0.582) group at 5-day. Conclusions: Substantial differences in the clinico-radiological evolution of acute ischemic stroke exist according to stroke mechanism. These data emphasize the importance of the stroke mechanism in the design of MRI-based acute stroke trials. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 27 条
  • [1] An evidence-based causative classification system for acute ischemic stroke
    Ay, H
    Furie, KL
    Singhal, A
    Smith, WS
    Sorensen, AG
    Koroshetz, WJ
    [J]. ANNALS OF NEUROLOGY, 2005, 58 (05) : 688 - 697
  • [2] Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging
    Bardutzky, J
    Shen, Q
    Henninger, N
    Bouley, J
    Duong, TQ
    Fisher, M
    [J]. STROKE, 2005, 36 (09) : 2000 - 2005
  • [3] Mapping the ischaemic penumbra with PET: Implications for acute stroke treatment
    Baron, JC
    [J]. CEREBROVASCULAR DISEASES, 1999, 9 (04) : 193 - 201
  • [4] MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE
    BROTT, T
    ADAMS, HP
    OLINGER, CP
    MARLER, JR
    BARSAN, WG
    BILLER, J
    SPILKER, J
    HOLLERAN, R
    EBERLE, R
    HERTZBERG, V
    RORICK, M
    MOOMAW, CJ
    WALKER, M
    [J]. STROKE, 1989, 20 (07) : 864 - 870
  • [5] Proof-of-principle phase II MRI studies in stroke -: Sample size estimates from dichotomous and continuous data
    Donnan, Geoffrey A.
    Davis, Stephen M.
    Phan, Thanh G.
    Ludbrook, John
    Byrnes, Graham
    Parsons, Mark
    Barber, Alan P.
    Reutens, David C.
    Rose, Stephen E.
    Chalk, Jonathan
    Demchuk, Andrew M.
    Coutts, Shelagh B.
    Simon, Jessica E.
    Tomanek, Anna
    Roether, Joachim
    Weiller, Comelius
    Fiehler, Jens
    Thomalla, Gotz
    Kucinski, Thomas
    Schellinger, Peter D.
    Hacke, Werner
    Gass, Achim
    Szabo, Kristina
    Hennerici, Michael
    Siebler, Mario
    Villringer, Arno
    Junge-Huelsing, G. J.
    Pedraza, Salvador
    Davalos, Antoni
    Castillo, Jose
    Albers, Gregory W.
    Lansberg, Maarten G.
    Thijs, Vincent N.
    Bammer, Roland
    Moseley, Michael E.
    Marks, Michael
    Warach, Steve
    Baird, Alison
    Kidwell, Chelsea
    Saver, Jeff
    Sorensen, Greg
    Fisher, Marc
    Nighoghossian, Norbert
    Muir, Keith
    [J]. STROKE, 2006, 37 (10) : 2521 - 2525
  • [6] FIELLER EC, 1957, BIOMETRIKA, V44, P470, DOI 10.2307/2332878
  • [7] New perspectives on developing acute stroke therapy
    Fisher, M
    Ratan, R
    [J]. ANNALS OF NEUROLOGY, 2003, 53 (01) : 10 - 20
  • [8] THE ISCHEMIC PENUMBRA, INJURY THRESHOLDS, AND THE THERAPEUTIC WINDOW FOR ACUTE STROKE
    GINSBERG, MD
    PULSINELLI, WA
    [J]. ANNALS OF NEUROLOGY, 1994, 36 (04) : 553 - 554
  • [9] FUNCTIONAL IMPAIRMENT DUE TO WHITE MATTER ISCHEMIA AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION IN CATS
    GRAF, R
    KATAOKA, K
    WAKAYAMA, A
    ROSNER, G
    HAYAKAWA, T
    HEISS, WD
    [J]. STROKE, 1990, 21 (06) : 923 - 928
  • [10] The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase
    Hacke, W
    Albers, G
    Al-Rawi, Y
    Bogousslavsky, J
    Davalos, A
    Eliasziw, M
    Fischer, M
    Furlan, A
    Kaste, M
    Lees, KR
    Soehngen, M
    Warach, S
    [J]. STROKE, 2005, 36 (01) : 66 - 73